Genetic Basis of Rosacea
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02787616 |
Recruitment Status :
Completed
First Posted : June 1, 2016
Last Update Posted : September 26, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Rosacea | Genetic: buccal swab |
Study Type : | Observational |
Actual Enrollment : | 306 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Validation of Candidate Rosacea Genes By Targeted Interrogation of Alleles and Assessment of Rosacea Co-morbidities |
Actual Study Start Date : | April 13, 2012 |
Actual Primary Completion Date : | November 16, 2018 |
Actual Study Completion Date : | November 16, 2018 |

Group/Cohort | Intervention/treatment |
---|---|
Rosacea Group |
Genetic: buccal swab
cheek swab for DNA sampling |
Non-Rosacea Group |
Genetic: buccal swab
cheek swab for DNA sampling |
- Targeted interrogation of alleles and assessment of rosacea co-morbidities. [ Time Frame: Up to 2 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Eligibility Criteria for Rosacea Group:
Inclusion criteria for rosacea participants:
- Clinical signs and symptoms of rosacea (papulopustular or erythrotelangiectatic subtypes) present at enrollment as determined by the investigator
- All four grandparents of European descent
- Fitzpatrick skin type I or II
- Age 18 years or older
Exclusion criteria for rosacea participants:
- Unable or unwilling to provide written informed consent
- Concomitant facial or medical condition that obscures diagnosis of rosacea (such as malar erythema from lupus erythematosus)
- Acne vulgaris
- Unable or unwilling to provide peripheral blood sample (a few teaspoons)
- Inability for investigator to verify rosacea diagnosis on clinical examination due to rosacea treatment(s) leading to complete lack of signs and symptoms (such prior laser treatments, systemic tetracycline usage, etc.)
- Use of topical prescription medications or procedures to the face within one month of enrollment
- Women who are pregnant or lactating
Eligibility Criteria for Non-Rosacea Group:
Inclusion criteria for control participants:
- No history of rosacea
- No clinical signs or symptoms of rosacea
- No family history of rosacea
- All four grandparents of European descent
- Fitzpatrick skin type I or II
- Age 18 years or older
Exclusion criteria for control participants:
- Unable or unwilling to provide written informed consent
- Acne vulgaris
- Unable or unwilling to provide peripheral blood sample (a few teaspoons)
- Women who are pregnant or lactating
- Use of topical prescription medications or procedures to the face within one month of enrollment
- Skin conditions that might interfere with interpretation of procedure results (at the discretion of the investigator)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02787616
United States, California | |
Stanford Dermatology | |
Redwood City, California, United States, 94603 |
Responsible Party: | Anne Chang, Associate Professor of Dermatology, Stanford University |
ClinicalTrials.gov Identifier: | NCT02787616 |
Other Study ID Numbers: |
R15006 |
First Posted: | June 1, 2016 Key Record Dates |
Last Update Posted: | September 26, 2019 |
Last Verified: | September 2019 |
Rosacea Skin Diseases |